These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1026816)

  • 41. Effect of simultaneous administration of interferon-gamma and chemotherapy against Mycobacterium leprae in experimental infection in nude mice.
    Banerjee DK; McDermott-Lancaster RD
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):690-6. PubMed ID: 2126271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lepromatous leprosy.
    Johnston SM; Ryan TJ
    Proc R Soc Med; 1973 Feb; 66(2):181-2. PubMed ID: 4714658
    [No Abstract]   [Full Text] [Related]  

  • 43. [Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy].
    Pattyn SR; Husser JA; Saint-André P
    Acta Leprol; 1986; 4(4):445-6. PubMed ID: 3296614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bacteriologic study in patients with multibacillary leprosy treated with rifampicin and acedapsone].
    Olivares Sabournin R; González Segredo AB
    Rev Cubana Med Trop; 1989; 41(2):307-12. PubMed ID: 2486227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapeutic effect of rifampicin (RFP) on leprosy. II. On the changes of the morphological index of M. leprae in patients (author's transl)].
    Ozawa T
    Repura; 1974; 43(1):26-34. PubMed ID: 4610308
    [No Abstract]   [Full Text] [Related]  

  • 46. Single-dose rifampicin, oflaxicin and minocycline (ROM) therapy for single leprosy lesions.
    Ramu G
    Lepr Rev; 1998 Mar; 69(1):78-82. PubMed ID: 9628098
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for the activity of rifampin on the neuropathy of foot pad-inoculated mice with Mycobacterium leprae.
    Sebille A; Crepon MO; Guelpa CC; Grosset J
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):481-3. PubMed ID: 2995517
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of two multidrug regimens in multibacillary leprosy.
    Jadhav VH; Patki AH; Mehta JM
    Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activity of two doses of rifampin against Mycobacterium leprae.
    Husser JA; Traore I; Daumerie D
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cell-mediated immunity in patients with leprosy treated with rifampicin].
    Valdés-Portela A; de la Cruz F
    Rev Cubana Med Trop; 1987; 39(3):23-32. PubMed ID: 3327106
    [No Abstract]   [Full Text] [Related]  

  • 54. An unusual reaction to rifampicin in a once monthly dose.
    Sule RR
    Lepr Rev; 1996 Sep; 67(3):227-8. PubMed ID: 8885617
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of drug regimen in lepromatous leprosy--II.
    Ramu G; Sreevatsa
    Lepr India; 1983 Apr; 55(2):200-8. PubMed ID: 6195452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hansen's disease (tuberculoid form). Therapeutic success with rifampicin].
    Korting GW
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(3):234. PubMed ID: 5134958
    [No Abstract]   [Full Text] [Related]  

  • 57. Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment.
    Warndorff van Diepen T; Mengistu G
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):189-97. PubMed ID: 2410520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rifampicin in renal transplant.
    Rao SP; Rajasekar M; Ravichandran R
    J Assoc Physicians India; 1990 Oct; 38(10):822. PubMed ID: 2084108
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of rifampicin for leprosy: comparative study with several doses and intervals of administration.
    Namba M; Hazama S
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):198. PubMed ID: 945236
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug interactions -- the influence of rifampicin and clofazimine on the urinary excretion of DDS.
    Balakrishnan ; Seshadri PS
    Lepr India; 1981 Jan; 53(1):17-22. PubMed ID: 7218762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.